IpsiHand Upper Extremity Rehabilitation System
Upper extremity motor function rehabilitation in chronic stroke survivors
ApprovedActive
Key Facts
Indication
Upper extremity motor function rehabilitation in chronic stroke survivors
Phase
Approved
Status
Active
Company
About NeuroLutions
NeuroLutions is a commercial-stage medical device company pioneering a novel approach to stroke recovery. Its FDA-cleared IpsiHand system is a first-of-its-kind BCI therapy that enables patients to use signals from their uninjured brain hemisphere to drive movement in their impaired hand, offering hope beyond the traditional recovery plateau. The company has transitioned from R&D through regulatory milestones to a full market launch in 2024, focusing on home-based rehabilitation covered by major insurers. NeuroLutions represents a significant innovation in the neurorehabilitation space, targeting the large and underserved chronic stroke population.
View full company profile